登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>Tau >TAU-H5143

Human Tau-410 / 2N3R Protein, His Tag, low endotoxin (MALS verified)

分子别名(Synonym)

DDPAC,FTDP-17,MAPT,MSTD,MTBT1,Tau,PHF-tau,TAU

表达区间及表达系统(Source)

Human Tau-410, His Tag (TAU-H5143) is expressed from E. coli cells. It contains AA Met 1 - Leu 410 (Accession # P10636-5).

Predicted N-terminus: His

Request for sequence

蛋白结构(Molecular Characterization)

Tau Structure

This protein carries a polyhistidine tag at the N-terminus.

The protein has a calculated MW of 44.5 kDa. The protein migrates as 55-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

内毒素(Endotoxin)

Less than 0.01 EU per μg by the LAL method.

纯度(Purity)

>90% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

制剂(Formulation)

Supplied as 0.2 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.

Contact us for customized product form or formulation.

运输(Shipping)

This product is supplied and shipped with dry ice, please inquire the shipping cost.

存储(Storage)

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 

电泳(SDS-PAGE)

Tau SDS-PAGE

Human Tau-410, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

SEC-MALS

Tau SEC-MALS

The purity of Human Tau-410, His Tag (Cat. No. TAU-H5143) is more than 90% and the molecular weight of this protein is around 40-60 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-ELISA

Tau ELISA

Immobilized Human Tau-410, His Tag (Cat. No. TAU-H5143) at 1 μg/mL (100 μL/well) can bind Tau Monoclonal Antibody with a linear range of 0.2-4 ng/mL (QC tested).

Protocol

 
评论(0)
 
ACRO质量管理体系
 
 

背景(Background)

Tau is a microtubule-associated protein, which encodes by the MAPT gene that located on chromosome 17q21. Tau Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. Hyperphosphorylation of the tau protein (tau inclusions, pTau) can result in the self-assembly of tangles of paired helical filaments and straight filaments, which are involved in the pathogenesis of Alzheimer's disease, frontotemporal dementia, and other tauopathies.

 

前沿进展

Metformin Improves Spatial Memory and Reduces Seizure Severity in a Rat Model of Epilepsy and Alzheimer's Disease comorbidity via PI3K/Akt Signaling Pathway
Alves, Rossi, de Oliveira et al
Mol Neurobiol (2025)
Abstract: Emerging evidence suggests a bidirectional relationship between Alzheimer's disease (AD) and epilepsy. In our previous studies, we identified a partial AD-like phenotype associated with central insulin resistance in the Wistar audiogenic rat (WAR), a genetic model of epilepsy. We also found that intracerebroventricular administration of streptozotocin, a compound used to model diabetes and AD, exacerbates seizure susceptibility. Given the role of insulin signaling in both AD and epilepsy, we hypothesized that metformin (MET), an anti-diabetic drug known for enhancing insulin sensitivity, could be a potential therapeutic agent for both conditions. Our objective was to investigate MET's effects on brain insulin signaling, seizure activity, and AD-like pathology in WARs. Adult male WARs received oral MET (250 mg/kg) for 21 days. Audiogenic seizures were assessed using the Categorized Severity Index and Racine's scale. Spatial memory was tested with the Morris water maze (MWM), followed by Western blot analysis of hippocampal proteins. MET significantly reduced seizure severity and improved MWM performance. Although MET did not affect insulin receptor levels or activation, it increased phosphoinositide 3-kinase (PI3K), activated Akt, and increased glycogen synthase kinase-3α/β (GSK-3α/β) levels. MET also decreased amyloid β precursor protein (AβPP) levels but did not affect Tau phosphorylation. These results suggest that chronic MET treatment alleviates behaviors related to both AD and epilepsy in WARs and modulates insulin signaling independently of insulin receptor activation. Our findings highlight MET's potential as a therapeutic agent for managing comorbid AD and epilepsy, warranting further investigation into its mechanisms of action.© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Biomarkers in dementia disorders - a narrative review
Hasselbalch
Dan Med J (2025) 72 (3)
Abstract: With the introduction of specific or unspecific biomarkers, the diagnosis of dementia disorders has changed from a purely clinical to a biological construct. This review presents biomarkers for the most common neurodegenerative disorders. Specific biomarkers for misfolded proteins have been developed for Alzheimer's disease and dementia with Lewy bodies. Unspecific biomarkers for neurodegeneration, synaptic dysfunction and neuroinflammation may also be helpful in diagnosing or staging dementia disorders.Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.
Diammonium phosphate supplementation in low-protein diets enhances growth performance in growing pigs without compromising carcass traits and meat quality
Zeng, Xiao, Liu et al
J Anim Sci (2025)
Abstract: Optimizing low-protein (LP) diets in swine nutrition is critical for reducing nitrogen excretion and resource waste, while reducing meat quality. However, LP diets may disrupt amino acid (AA) balance, affecting growth and health. Supplementing with non-protein nitrogen sources such as diammonium phosphate (DP) can enhance nitrogen utilization and support protein synthesis efficiently. This study aimed to investigate the effects of adding DP to LP diets on growth performance, organ indices, carcass traits, meat quality, and AA composition in growing pigs. Seventy-five barrows (Duroc × Landrace × Yorkshire) were randomly assigned to five dietary treatments: Pos Ctrl (CP: 13.50%), DP1 (CP: 12.00% + DP), DP2 (CP: 10.50% + DP), DP3 (CP: 9.00% + DP), and Neg Ctrl (CP: 9.00%). Each DP-supplemented diet aimed to maintain an essential AA nitrogen to total nitrogen (EAA-N/TN) ratio of 0.48. The pigs had free access to food and water for the 41-day experimental period, with body weight and feed intake were recorded monthly. After overnight fasting, pigs were euthanized, and carcass traits, meat quality, and organ indices were assessed. Blood, liver, and muscle samples were collected for analyses of plasma biochemistry, and AA profiles. The study found that feeding the DP2 diet resulted in the best growth performance, while the DP3 diet significantly improved ADG and G:F compared to the Neg Ctrl diet. The DP3 diet also significantly increase relative liver weight compared to the Neg Ctrl diet. Although no significant differences were observed in carcass traits or meat quality among the dietary treatments, the DP3 diet had a tendency to reduced plasma total protein levels relative to the Neg Ctrl diet. Feeding the DP3 diet did not alter the free AA profile in plasma and liver of growing pigs compared with the Neg Ctrl diet, and there was no effect between the different diets on the hydrolyzed AA profile in muscle. Furthermore, the DP3 diet significantly increased Tau concentrations in the longissimus dorsi muscle (LM) while significantly reducing Car levels compared to the Neg Ctrl diet. In conclusion, these results suggest that adding DP to the LP diet can enhance growth performance and improve meat flavor-related AA content without compromising carcass traits or meat quality.© The Author(s) 2025. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Concentration-Based Analysis of Metal-Induced Tau Fibrillar versus non-fibrillar Aggregation: Implications for Neurotoxicity in Alzheimer's Disease
Irandoust, Anbaraki, Dindar et al
ChemistryOpen (2025)
Abstract: Tau protein aggregation is the most significant factor in Alzheimer's disease (AD) pathogenesis, and the accumulation of metal ions in the brain is considered a key factor in the development of this disease. Tau protein exhibits two distinct aggregate structures: fibrillar and non-fibrillar aggregates. In this study, we conducted the first detailed study of the interactions of tau protein with three different concentrations of Zn2+, Cu2+, and Fe3+ions. Our findings demonstrate that low concentrations (0.01 mM) of these metal ions promote tau fibrillation, while higher concentrations (1 mM) induce non-fibrillar aggregates. We have investigated the structural changes of tau by using advanced techniques such as SDS-PAGE, DTNB, AFM, CD and fluorescence spectroscopy. At low concentrations, Zn2+ ions produced shorter fibrils, whereas Cu2+ and Fe3+ ions resulted in longer fibrils. CD showed increased β-sheet structures with a decrease in random coil content. Interestingly, Cu2+ ions caused a significant decrease in neuronal viability. Our data highlights a new approach that illuminates the different ways in which the metal ions distinctively cause tau fibrillar versus non-fibrillar aggregates, linked to neurotoxicity and neurodegeneration.© 2025 The Authors. ChemistryOpen published by Wiley-VCH GmbH.
Showing 1-4 of 81863 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
Tau靶点信息
英文全称:Microtubule-associated protein tau
中文全称:微管相关蛋白tau
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:38详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All Tau

消息提示

请输入您的联系方式,再点击提交!

确定